QIAGEN NV (QGEN)
50.32
-0.54
(-1.06%)
USD |
NYSE |
Nov 06, 16:00
50.40
+0.08
(+0.16%)
After-Hours: 16:37
QIAGEN Research and Development Expense (Annual) : 187.52M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 187.52M |
| December 31, 2024 | 193.49M |
| December 31, 2023 | 198.51M |
| December 31, 2022 | 189.86M |
| December 31, 2021 | 189.96M |
| December 31, 2020 | 149.07M |
| December 31, 2019 | 157.45M |
| December 31, 2018 | 161.85M |
| December 31, 2017 | 154.08M |
| December 31, 2016 | 149.78M |
| December 31, 2015 | 147.18M |
| December 31, 2014 | 157.81M |
| December 31, 2013 | 148.17M |
| December 31, 2012 | 128.28M |
| December 31, 2011 | 125.14M |
| December 31, 2010 | 126.04M |
| Date | Value |
|---|---|
| December 31, 2009 | 107.90M |
| December 31, 2008 | 97.33M |
| December 31, 2007 | 64.94M |
| December 31, 2006 | 41.56M |
| December 31, 2005 | 39.10M |
| December 31, 2004 | 35.77M |
| December 31, 2003 | 31.79M |
| December 31, 2002 | 28.18M |
| December 31, 2001 | 26.77M |
| December 31, 2000 | 22.21M |
| December 31, 1999 | 16.27M |
| December 31, 1998 | 25.43M |
| December 31, 1997 | 16.17M |
| December 31, 1996 | 10.97M |
| December 31, 1995 | 7.045M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Illumina, Inc. | 951.00M |
| Thermo Fisher Scientific, Inc. | 1.397B |
| Bio-Rad Laboratories, Inc. | 257.60M |
| Waters Corp. | 195.18M |
| Agilent Technologies, Inc. | 450.00M |